Shares outstanding · 2019–2025

Keros Therapeutics shares outstanding

19.5M−51.8% · FY2025

Keros Therapeutics (KROS) reported 19.5M in shares outstanding for fiscal 2025, −51.8% year on year.

2.4M201923.2M202024.0M202127.5M202231.8M202340.6M202419.5M2025
Keros Therapeutics — Shares outstanding, 2019–2025
Fiscal yearShares outstandingChangeFiling
FY20252025-12-3119.5M−51.8%Open →
FY20242024-12-3140.6M+27.4%Open →
FY20232023-12-3131.8M+15.6%Open →
FY20222022-12-3127.5M+14.9%Open →
FY20212021-12-3124.0M+3.4%Open →
FY20202020-12-3123.2M+854.6%Open →
FY20192019-12-312.4M—Open →

Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +41.5%

Shares outstanding at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Keros Therapeutics shares outstanding |url=https://companiesranked.com/en/company/keros-therapeutics/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Keros Therapeutics shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/keros-therapeutics/shares-outstanding

BibTeX

@misc{companiesranked-en-company-keros-therapeutics-shares-outstanding-2026,
  author       = {{CompaniesRanked}},
  title        = {{Keros Therapeutics shares outstanding}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/keros-therapeutics/shares-outstanding}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001664710-26-000049 · August 3, 2026

{{cite web |title=Keros Therapeutics shares outstanding — 10-Q (0001664710-26-000049) |url=https://www.sec.gov/Archives/edgar/data/1664710/000166471026000049/kros-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Keros Therapeutics overview